A detailed history of Ariadne Wealth Management, LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Ariadne Wealth Management, LP holds 1,203 shares of LLY stock, worth $1.08 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
1,203
Previous 1,121 7.31%
Holding current value
$1.08 Million
Previous $894 Million 16.96%
% of portfolio
0.48%
Previous 0.49%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$727.2 - $932.06 $59,630 - $76,428
82 Added 7.31%
1,203 $1.05 Billion
Q3 2024

Nov 08, 2024

BUY
$772.14 - $960.02 $865,568 - $1.08 Million
1,121 New
1,121 $894 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $857B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ariadne Wealth Management, LP Portfolio

Follow Ariadne Wealth Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ariadne Wealth Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Ariadne Wealth Management, LP with notifications on news.